knowledge -WSS

knowledge

author：focus 2025-09-29 12:30:35 - browse：12

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Inaction leaves children at risk from dangerous chemotherapy drug

WSS

Kidney transplant patients stopped immunosuppressants in trial

Dana Farber says 6 studies to be retracted and 31 corrected

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Update the Apgar Score to remove skin color

The inclusion problem at the heart of rehabilitation research

focus

knowledge

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lung cancer screening guidelines updated for cigarette smokers

Medicare details structure of new drug price negotiation program

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Supreme Court strikes down use of affirmative action

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

New air purifier tech could be key to improving indoor air quality

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Inari Medical to buy amputation prevention company LimFlow

knowledge

Maisha Meds is a PBM, but don't call it that

What is microchimerism and how does it affect maternal health?

Coloradans with cystic fibrosis could lose access to Trikafta

Mass General, Mayo Clinic look to monetize custom

The inclusion problem at the heart of rehabilitation research

HPV vaccine, cervical cancer study delivers historic results

focus

entertainment

hotspot

hotspot